Akonni Biosystems

Akonni Biosystems operates in the molecular diagnostics market, focusing on the development and large-scale manufacturing of cost-effective genetic testing devices. The company specializes in addressing complex infectious diseases, such as multi-drug-resistant tuberculosis (MDR-TB). Utilizing a revolutionary gel-drop microarray platform, Akonni provides sophisticated yet affordable solutions for high-yield sample preparation and multiplex array imaging and analysis. The business model revolves around selling these diagnostic devices and associated instrumentation to healthcare providers, research institutions, and laboratories. Revenue is generated through the sale of these products, which are designed to offer high accuracy and efficiency in disease detection and management.

Keywords: molecular diagnostics, genetic testing, infectious diseases, MDR-TB, gel-drop microarray, sample preparation, multiplex array, healthcare, laboratories, cost-effective.